Therefore, our prior (canine lymphoma [9]) and current observations that APC activation reverses MDR cancer behavior applies to different cell line models (breast cancer and lymphoma), across species lines (canine and humans), in vitro and in vivo (cell line, canine, and PDX mouse models), and to different methods of selecting cells for resistance (DOX and TAM). This evidence concerns the gene APC and cancer.